Fig 3.
Correlations between T-cell persistence and enzyme-linked immunosorbent spot (ELISPOT) responses. Highly significant correlations were found (A) between NY-ESO-1 tetramer and Vβ13.1 expression (r2 = 0.82; P < .001), (B) between NY-ESO-1 peptide–reactive interferon gamma (IFN-γ) ELISPOTs and NY-ESO-1 tetramer expression (r2 = 0.72; P < .001), and (C) between NY-ESO-1 peptide–reactive ELISPOTs and Vβ13.1 expression (r2 = 0.70; P < .001) in patient peripheral-blood mononuclear cells (PBMCs) obtained approximately 1 month after adoptive transfer.